In contrast, Soo-PCR offers superior sensitivity and specificity, facilitating on–off discrimination against three major cancer markers (KRAS G12D, EGFR L858R, and EGFR T790M) present in low abundance (0.1% VAF, approximately 17 copies) in cfDNA samples closely resembling clinical samples in under 2 h. Here, KRAS is linked to cancer.